Patent · US Active

Cannabinoid receptor mediating compounds

US11939297B2 · kind B2 · utility

0Cited by

6References

2Claims

0Family size

Assignee

The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

George Kunos · Bethesda, US
Malliga Iyer · Germantown, US
Resat Cinar · Bethesda, US
Kenner C. Rice · Bethesda, US

Key dates

Filing date	Feb 10, 2023
Grant date	Mar 26, 2024
Priority date	—
Expiry date	Feb 10, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.